Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.

Education

Manufacturing

Pharmaceutical

Therapeutics

Vigil Neuro

Vigil Neuro's headquarters in Cambridge, MA, United States

Kevin Durfee

Brenda Duane

David Gray

Weeteck Yeo

Clarissa Martinez-Rubio

Jennifer Ziolkowski

April Effort

Sharon Morani

Rizwan Manzer

Pam Meneses

Humann Hodjatzadeh

Andreas Meier

Jonathan Houze

Berkley Lynch

John Dunlop

Jaime Grutzendler

Gerhard Koenig

Marco Colonna

Suzanne Bruhn

Mary Thistle

Ole Isacson

Stefan Vitorovic

Bradley Hyman

The Research and Development team at Vigil Neuro is dedicated to advancing the understanding and therapeutic potential of microglia in neurodegenerative diseases. They focus on discovering and optimizing novel compounds, translating scientific findings into actionable therapies, and ensuring rigorous quality standards throughout the drug development process. By leveraging expertise in various scientific disciplines, the team aims to deliver innovative, precision-based therapies to improve patient outcomes.

Research and Development

This department provides strategic oversight and direction for the organization.

Leadership Council

This department provides essential administrative assistance and coordination to executives and key operational functions.

Administrative Support

This department focuses on conducting scientific research and experiments in the field of biology.

Biological Research

The Finance and Accounting team at Vigil Neuro is responsible for managing the company's financial health, including budgeting, forecasting, and financial reporting. They ensure accurate accounting practices, maintain compliance with regulations, and support strategic decision-making through financial analysis. This team plays a critical role in enabling Vigil Neuro to invest in innovative therapies for neurodegenerative diseases while maintaining financial stability.

Finance and Accounting

This department manages the organization's financial planning, analysis, and reporting.

Finance Department

Vigil Neuro

Org chart

Board & advisors

Teams

Research and Development

Leadership Council

Administrative Support

Biological Research

Finance and Accounting

Finance Department

Offices

Vigil Neuro

Org chart

Board & advisors

Teams

Research and Development

Leadership Council

Administrative Support

Biological Research

Finance and Accounting

Finance Department

Offices

Related companies